Innovent Receives FDA Approval to Start Anti-CD47 Monoclonal Antibody IBI-188 Trial

Company

About Us Terms of Service Privacy Policy Contact Us

Publish on TrialSite

Writing Best Practices Why TrialSite?

Follow Us

TrialSiteNews

159 W Broadway, Suite 200

Salt Lake City, UT 84101

© 2025 - Trial Site News